nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP19A1—semen—acquired immunodeficiency syndrome	0.0687	0.0905	CbGeAlD
Masoprocol—LTB4R—skin of body—acquired immunodeficiency syndrome	0.0395	0.052	CbGeAlD
Masoprocol—IGF1R—skin of body—acquired immunodeficiency syndrome	0.0326	0.0429	CbGeAlD
Masoprocol—LTB4R—lymphoid tissue—acquired immunodeficiency syndrome	0.032	0.0421	CbGeAlD
Masoprocol—LTB4R—blood—acquired immunodeficiency syndrome	0.0301	0.0396	CbGeAlD
Masoprocol—LTB4R—bone marrow—acquired immunodeficiency syndrome	0.0291	0.0384	CbGeAlD
Masoprocol—LTB4R—vagina—acquired immunodeficiency syndrome	0.0279	0.0368	CbGeAlD
Masoprocol—IGF1R—lymphoid tissue—acquired immunodeficiency syndrome	0.0264	0.0348	CbGeAlD
Masoprocol—LTB4R—lung—acquired immunodeficiency syndrome	0.0264	0.0348	CbGeAlD
Masoprocol—IGF1R—digestive system—acquired immunodeficiency syndrome	0.0261	0.0344	CbGeAlD
Masoprocol—IGF1R—blood—acquired immunodeficiency syndrome	0.0248	0.0327	CbGeAlD
Masoprocol—IGF1R—vagina—acquired immunodeficiency syndrome	0.023	0.0303	CbGeAlD
Masoprocol—CYP2J2—skin of body—acquired immunodeficiency syndrome	0.0221	0.0291	CbGeAlD
Masoprocol—IGF1R—lung—acquired immunodeficiency syndrome	0.0218	0.0287	CbGeAlD
Masoprocol—IGF1R—nervous system—acquired immunodeficiency syndrome	0.0202	0.0266	CbGeAlD
Masoprocol—IGF1R—central nervous system—acquired immunodeficiency syndrome	0.0194	0.0256	CbGeAlD
Masoprocol—LTB4R—brain—acquired immunodeficiency syndrome	0.0187	0.0246	CbGeAlD
Masoprocol—LTB4R—lymph node—acquired immunodeficiency syndrome	0.018	0.0238	CbGeAlD
Masoprocol—CYP2J2—spinal cord—acquired immunodeficiency syndrome	0.0162	0.0214	CbGeAlD
Masoprocol—CYP2J2—vagina—acquired immunodeficiency syndrome	0.0156	0.0206	CbGeAlD
Masoprocol—IGF1R—brain—acquired immunodeficiency syndrome	0.0154	0.0203	CbGeAlD
Masoprocol—IGF1R—lymph node—acquired immunodeficiency syndrome	0.0149	0.0196	CbGeAlD
Masoprocol—CYP2J2—lung—acquired immunodeficiency syndrome	0.0148	0.0194	CbGeAlD
Masoprocol—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.0141	0.0186	CbGeAlD
Masoprocol—ALOX5—digestive system—acquired immunodeficiency syndrome	0.0139	0.0183	CbGeAlD
Masoprocol—CYP2J2—nervous system—acquired immunodeficiency syndrome	0.0137	0.018	CbGeAlD
Masoprocol—ALOX5—blood—acquired immunodeficiency syndrome	0.0133	0.0175	CbGeAlD
Masoprocol—CYP2J2—central nervous system—acquired immunodeficiency syndrome	0.0132	0.0173	CbGeAlD
Masoprocol—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.0128	0.0169	CbGeAlD
Masoprocol—ALOX5—lung—acquired immunodeficiency syndrome	0.0116	0.0153	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0111	0.0458	CbGpPWpGaD
Masoprocol—ALOX5—nervous system—acquired immunodeficiency syndrome	0.0108	0.0142	CbGeAlD
Masoprocol—CYP2J2—brain—acquired immunodeficiency syndrome	0.0104	0.0138	CbGeAlD
Masoprocol—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.0104	0.0137	CbGeAlD
Masoprocol—CYP19A1—blood—acquired immunodeficiency syndrome	0.00917	0.0121	CbGeAlD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	0.00843	0.0349	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00842	0.0349	CbGpPWpGaD
Masoprocol—ALOX5—brain—acquired immunodeficiency syndrome	0.00823	0.0108	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00817	0.0339	CbGpPWpGaD
Masoprocol—ALOX5—lymph node—acquired immunodeficiency syndrome	0.00795	0.0105	CbGeAlD
Masoprocol—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.00744	0.00981	CbGeAlD
Masoprocol—IGF1R—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.00736	0.0305	CbGpPWpGaD
Masoprocol—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.00717	0.00944	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0067	0.0278	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00606	0.0251	CbGpPWpGaD
Masoprocol—CYP19A1—brain—acquired immunodeficiency syndrome	0.00569	0.0075	CbGeAlD
Masoprocol—LTB4R—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.00566	0.0235	CbGpPWpGaD
Masoprocol—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.0055	0.00724	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.00526	0.0218	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	0.00514	0.0213	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.0051	0.0211	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00461	0.0191	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.00457	0.0189	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00437	0.0181	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00432	0.0179	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00414	0.0172	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00411	0.017	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00405	0.0168	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00374	0.0155	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00352	0.0146	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00352	0.0146	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.00342	0.0142	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00324	0.0134	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	0.0032	0.0132	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00315	0.0131	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.00304	0.0126	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00289	0.012	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00285	0.0118	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00282	0.0117	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.00268	0.0111	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00268	0.0111	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00268	0.0111	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00268	0.0111	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00264	0.0109	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00262	0.0108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00255	0.0106	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.00247	0.0102	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—acquired immunodeficiency syndrome	0.00247	0.0102	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00241	0.01	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00241	0.00998	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00237	0.00981	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.00222	0.00918	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00217	0.009	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00204	0.00845	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.00191	0.00789	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.00186	0.00769	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00184	0.00761	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.00179	0.00741	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TAT—acquired immunodeficiency syndrome	0.0017	0.00704	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	0.00167	0.00692	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00162	0.0067	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00161	0.00668	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00156	0.00646	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00155	0.00641	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00155	0.00641	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00151	0.00628	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00151	0.00628	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TAT—acquired immunodeficiency syndrome	0.00151	0.00627	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00149	0.00617	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00146	0.00606	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00144	0.00598	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.0014	0.0058	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00138	0.0057	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00138	0.0057	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00132	0.00545	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00132	0.00545	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00129	0.00533	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00126	0.00521	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00119	0.00493	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00115	0.00477	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00114	0.0047	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00111	0.00458	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00105	0.00434	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00104	0.0043	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00103	0.00427	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000956	0.00396	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000943	0.00391	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000864	0.00358	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000813	0.00337	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000813	0.00337	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000813	0.00337	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00078	0.00323	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000735	0.00304	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000691	0.00286	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000691	0.00286	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000665	0.00276	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000663	0.00275	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000618	0.00256	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000609	0.00252	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.0006	0.00249	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000593	0.00246	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000557	0.00231	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000545	0.00226	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000526	0.00218	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000518	0.00215	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000474	0.00196	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000322	0.00133	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00032	0.00133	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000305	0.00127	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000296	0.00123	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000274	0.00113	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	0.000264	0.00109	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000189	0.000784	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000161	0.000666	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000136	0.000563	CbGpPWpGaD
